Buy & Sell Crispr Therapeutics AG (CRSP) – Crispr Therapeutics AG Price Today
Aura AI Summary
Key Stats
- $5.41BMarket Cap
- HealthSector
- -17.93%3M Drawdown
- $3.75BEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 71 daysTypical Hold Time
Crispr Therapeutics AG (CRSP) is currently valued at a market capitalization of $5.41B, with an enterprise value of $3.75B. Over the past 52 weeks, Crispr Therapeutics AG has traded between a low of $44.34 and a high of $76.78, highlighting its annual price range. Over the past three months, Crispr Therapeutics AG has recorded a drawdown of -17.93%, reflecting recent price volatility. On average, investors hold Crispr Therapeutics AG for approximately 71 days, indicating typical investor behavior on the platform.
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Most Recent News
Global solar backsheet market to nearly double to $6.91B by 2035, driven by rising solar installations and tech advances.
The global solar backsheet market, valued at $3.84 billion in 2025, is projected to grow to $6.91 billion by 2035 at a CAGR of 6.74%. Growth is fueled by increasing solar PV installations worldwide, investments in renewable energy infrastructure, and...
Global graphene chip market to reach $19.78B by 2035, driven by AI and nanoelectronics demand.
The global graphene chip market, valued at $4.41 billion in 2025, is projected to grow to $19.78 billion by 2035 with a CAGR of 16.2%. This growth is fueled by rising demand for advanced nanoelectronics, AI computing, and faster communication technol...
Global propionic acid market to reach $1.74B by 2035 driven by food, feed, and pharma demand
The global propionic acid market, valued at $1.22 billion in 2025, is projected to grow to $1.74 billion by 2035 at a CAGR of 3.63%. Growth is fueled by rising demand in food preservation, animal feed additives, pharmaceuticals, and agrochemicals. Su...